Vitamin B12 absorption is a complex physiological process that depends on a coordinated sequence of biochemical steps, each vulnerable to disruption by age, disease, or medication. Understanding this pathway helps explain why B12 deficiency can occur despite adequate dietary intake, and why certain populations—including older adults and those with gastrointestinal disease—face elevated risk.
- Step 1: B12 entry from food sources
- Step 2: Gastric acid and pepsin release B12 from proteins
- Step 3: Haptocorrin provides protective binding
- Step 4: Intrinsic factor takes over in the small intestine
- Step 5: Absorption in the terminal ileum via Cubam receptor
- Step 6: Transcobalamin-mediated blood transport
- Step 7: Cellular uptake and conversion to active cofactors
- Frequently asked questions
Key takeaways
- B12 absorption requires seven sequential biochemical steps, from food binding to cellular activation
- Intrinsic factor (IF) deficiency and gastric acid reduction are leading causes of B12 malabsorption
- B12 deficiency can cause neurological complications (neuropathy, cognitive impairment) if left untreated
- Ileal disease, antacid use, and pernicious anaemia each block distinct steps in the absorption pathway
The seven-step B12 absorption pathway
Sequential stages from food intake to cellular activation, with clinical intervention points
Illustrative model based on published B12 absorption physiology | Georgian Medical Journal News
Step 1: B12 entry from food sources
Vitamin B12 is present in animal-derived foods—meat, eggs, dairy, and fish—but exists in a protein-bound form that is not immediately bioavailable. The initial absorption process requires intact gastric physiology and adequate hydrochloric acid secretion.
This dietary dependency explains why strict vegetarians and vegans, as well as older adults with age-related gastric atrophy, face elevated risk of B12 deficiency. According to epidemiological data, vitamin B12 deficiency affects 10–30% of individuals over age 65, partly due to declining gastric acid production.
Step 2: Gastric acid and pepsin release B12 from proteins
Hydrochloric acid and the protease pepsin work to hydrolyse the protein-B12 complex, liberating free cobalamin in the stomach lumen. This step is critical: without adequate gastric acidity, B12 remains trapped in food proteins and cannot proceed further through the absorption pathway.
Proton pump inhibitors (PPIs) and H2-receptor antagonists, commonly used to treat gastro-oesophageal reflux disease and peptic ulcer disease, suppress gastric acid secretion and impair B12 release. Studies have documented that chronic PPI use is associated with increased risk of B12 malabsorption. Pernicious anaemia, caused by autoimmune destruction of gastric parietal cells, also prevents adequate acid production and contributes to profound B12 deficiency.
Step 3: Haptocorrin provides protective binding
Once released, free B12 is vulnerable to degradation in the acidic gastric environment. Haptocorrin (HC), a protective glycoprotein secreted in saliva and gastric mucus, rapidly binds B12 and shields it from chemical breakdown during passage through the stomach and into the small intestine.
This transient B12–haptocorrin complex is biochemically inert; B12 cannot be absorbed while bound to haptocorrin, so the complex serves a protective rather than absorptive function at this stage.
Step 4: Intrinsic factor takes over in the small intestine
In the duodenum and proximal jejunum, pancreatic proteases cleave haptocorrin, releasing B12 back into the intestinal lumen. Simultaneously, intrinsic factor (IF)—a glycoprotein synthesized by gastric parietal cells—is secreted and binds to the liberated B12 with high specificity and affinity.
The B12–IF complex is now in its absorptive form. Loss of intrinsic factor due to autoimmune gastritis (pernicious anaemia), gastrectomy, or chronic atrophic gastritis results in near-complete failure of B12 absorption. According to the American Gastroenterological Association, pernicious anaemia accounts for 25–50% of B12 deficiency in developed countries.
Loss of intrinsic factor—whether from autoimmune destruction, surgical gastrectomy, or atrophic gastritis—results in near-complete failure of B12 absorption and necessitates parenteral B12 supplementation for life.
— Published literature on B12 absorption physiology and pernicious anaemia pathophysiology
Step 5: Absorption in the terminal ileum via Cubam receptor
The B12–IF complex travels through the small bowel and docks on a specific receptor complex called Cubam (cubilin–amnionless) located on the brush border epithelium of the terminal ileum. This receptor-mediated endocytosis is the final gateway for B12 entry into intestinal epithelial cells.
Crohn’s disease affecting the ileum, surgical ileal resection, and genetic mutations affecting Cubam assembly all impair B12 absorption at this critical step. Patients with extensive ileal disease or post-surgical short bowel syndrome often require parenteral or high-dose oral B12 supplementation to bypass the defective absorptive step. See Clinical Updates for guidance on managing B12 deficiency in gastrointestinal disease.
Step 6: Transcobalamin-mediated blood transport
After crossing the intestinal epithelium, B12 enters the portal blood and binds to transcobalamin (TC), a carrier protein synthesized by the liver and other tissues. The B12–transcobalamin complex (also called holotranscobalamin or active B12) is the form recognized and taken up by peripheral tissues.
Serum B12 measured on routine laboratory tests includes both the biologically active TC-bound fraction and inactive cobalamin bound to other transport proteins (haptocorrin and albumin). This distinction explains why total serum B12 levels may be falsely reassuring in some patients with true B12 deficiency; testing for holotranscobalamin or methylmalonic acid provides more specific diagnostic information.
Step 7: Cellular uptake and conversion to active cofactors
Inside cells, B12 is converted to two enzymatically active forms: methylcobalamin and adenosylcobalamin. Methylcobalamin participates in the methionine synthase reaction, essential for DNA synthesis, myelin formation, and neurotransmitter production. Adenosylcobalamin is a cofactor for methylmalonyl-CoA mutase, a key enzyme in mitochondrial energy metabolism and branched-chain amino acid catabolism.
When cellular B12 levels fall, both reactions slow: impaired methylation compromises DNA replication and neurological function, while adenosylcobalamin deficiency impairs energy production, leading to fatigue and progressive neurological damage. Untreated B12 deficiency can cause irreversible peripheral neuropathy and subacute combined degeneration of the spinal cord.
What this means
Frequently asked questions
Can oral B12 supplements overcome intrinsic factor deficiency?
Partially. While high-dose oral B12 (typically 1,000–2,000 mcg daily) can achieve modest absorption via passive diffusion pathways that bypass the IF–Cubam mechanism, this approach is inefficient. Parenteral B12 (intramuscular injection monthly or quarterly) remains the standard treatment for pernicious anaemia because it achieves therapeutic serum levels reliably and completely bypasses the defective absorption pathway.
Why does B12 deficiency cause neurological symptoms?
B12-dependent methylation reactions are essential for myelin synthesis and maintenance of the spinal cord and peripheral nerves. Prolonged deficiency causes demyelination and axonal degeneration, leading to neuropathy, ataxia, and cognitive decline. These changes can become irreversible if B12 therapy is delayed, highlighting the importance of early diagnosis.
Are vegetarians at higher risk of B12 deficiency?
Yes. Since B12 is naturally present only in animal products, vegetarians and vegans must either consume fortified foods (plant-based milk, cereals, nutritional yeast) or take B12 supplements. Studies show that up to 80% of vegans without supplementation have suboptimal B12 status, underlining the need for deliberate dietary planning or supplementation.
Vitamin B12 absorption represents a sophisticated interplay of gastric, pancreatic, intestinal, and hepatic physiology. Understanding this seven-step pathway illuminates why B12 deficiency can result from seemingly minor disruptions—antacid use, minor ileal inflammation, or gradual parietal cell atrophy—and why prevention and early detection are clinically prudent. For more information on B12 assessment and management in clinical practice, consult Pharmacy & Prescribing guidance and related New Studies on nutritional deficiency management.
Source: Vitamin B12 absorption can be viewed as a biochemical obstacle course
Was this article helpful?
Disclaimer. This article is health journalism intended for general information and education. It is not medical advice and is not a substitute for professional diagnosis or treatment. Always consult a qualified healthcare provider about your individual circumstances. Full disclaimer →
Related Coverage
Editorial standards. This article was produced under the GMJ News editorial process, with oversight by the GMJ Editorial Board. Our editorial process. Spotted an error? Contact the editorial team.
